Hap Trading, LLC Atai Life Sciences N.V. Transaction History
Hap Trading, LLC
- $1.15 Trillion
- Q4 2024
A detailed history of Hap Trading, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Hap Trading, LLC holds 17,300 shares of ATAI stock, worth $25,604. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,300Holding current value
$25,604% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ATAI
# of Institutions
104Shares Held
16.3MCall Options Held
367KPut Options Held
69.2K-
Morgan Stanley New York, NY3.33MShares$4.93 Million0.0% of portfolio
-
Ubs Group Ag1.94MShares$2.87 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$1.93 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny982KShares$1.45 Million0.0% of portfolio
-
Davidson Kempner Capital Management LP New York, NY949KShares$1.41 Million0.03% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $245M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...